JETREA
Live / Registered — Cancelled — Section 71 (as of 25 Nov 2022)
What this means for you
Registered since 08 May 2012. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79098752
- Registration number
- 4137456
- Mark type
- Stylized text
- Filed
- 16 May 2011
- Published for opposition
- 21 Feb 2012
- Registered
- 08 May 2012
- Attorney of record
- Thomas J. Mango
Goods and services
- Class 001 — Chemicals: [ Chemical preparations and substances for use in the manufacture of pharmaceutical products and medicines ]
- Class 005 — Pharmaceuticals: [ Pharmaceutical preparations and substances for the treatment or prevention of cancer, diabetes, blood disorders and cardiovascular diseases; ] sanitary preparations for medical purposes; medicines for human purposes, namely, [ for treating or preventing oncological disorders and diseases, diabetes, gastrointestinal disease, blood disorders, and cardiovascular diseases, ] ophthalmic medicines and surgical fluids; pharmaceutical preparations, substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical eye drops
Owner
- Oxurion NV, BE
- ThromboGenics NV, BE
- ThromboGenics NV, BE
Prosecution history
- 26 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Jan 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 Sept 2023 — TOTAL INVALIDATION PROCESSED BY THE IB
- 21 Aug 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 21 Aug 2023 — INVALIDATION PROCESSED
- 25 Jul 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 25 Nov 2022 — CANCELLED SECTION 71
- 01 Jul 2021 — INTERNATIONAL REGISTRATION RENEWED
- 08 May 2021 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 13 Jun 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 08 Mar 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 26 Jan 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 26 Jan 2019 — INVALIDATION PROCESSED
- 12 Jan 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 28 Sept 2018 — NEW REPRESENTATIVE AT IB RECEIVED